Literature DB >> 21670181

Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.

Wang Hengzhuang1, Hong Wu, Oana Ciofu, Zhijun Song, Niels Høiby.   

Abstract

The time course of activity of colistin and imipenem against mucoid and nonmucoid Pseudomonas aeruginosa growing in a biofilm showed that compared with those for planktonic bacteria, the kinetics of colistin and imipenem retained the concentration- and time-dependent killing, respectively, but higher doses of antibiotics and longer dosing periods were required for biofilm eradication. Biofilms of mucoid P. aeruginosa were more difficult to eradicate than nonmucoid biofilms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670181      PMCID: PMC3165294          DOI: 10.1128/AAC.00126-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

Authors:  N Høiby; H Krogh Johansen; C Moser; Z Song; O Ciofu; A Kharazmi
Journal:  Microbes Infect       Date:  2001-01       Impact factor: 2.700

Review 3.  Animal model pharmacokinetics and pharmacodynamics: a critical review.

Authors:  D Andes; W A Craig
Journal:  Int J Antimicrob Agents       Date:  2002-04       Impact factor: 5.283

4.  Determination of minimum inhibitory concentrations.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

5.  Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa.

Authors:  H Wu; Z Song; M Hentzer; J B Andersen; A Heydorn; K Mathee; C Moser; L Eberl; S Molin; N Høiby; M Givskov
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 6.  Mechanisms of biofilm resistance to antimicrobial agents.

Authors:  T F Mah; G A O'Toole
Journal:  Trends Microbiol       Date:  2001-01       Impact factor: 17.079

Review 7.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

Authors:  G Döring; S P Conway; H G Heijerman; M E Hodson; N Høiby; A Smyth; D J Touw
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

8.  Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.

Authors:  Niels Bagge; Oana Ciofu; Morten Hentzer; Joan I A Campbell; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.

Authors:  M Hentzer; G M Teitzel; G J Balzer; A Heydorn; S Molin; M Givskov; M R Parsek
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 10.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  70 in total

Review 1.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

Review 2.  Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.

Authors:  Charlotte Roy; Manon Launay; Sophie Magréault; Isabelle Sermet-Gaudelus; Vincent Jullien
Journal:  Clin Pharmacokinet       Date:  2021-01-24       Impact factor: 6.447

3.  Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical Pseudomonas aeruginosa Biofilms.

Authors:  Megan P Jewell; Anne A Galyean; J Kirk Harris; Edith T Zemanick; Kevin J Cash
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

Review 4.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

5.  Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa.

Authors:  Mathias Müsken; Vinay Pawar; Timo Schwebs; Heike Bähre; Sebastian Felgner; Siegfried Weiss; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

6.  A New Tool to Reveal Bacterial Signaling Mechanisms in Antibiotic Treatment and Resistance.

Authors:  Miao-Hsia Lin; Clement M Potel; Kamaleddin H M E Tehrani; Albert J R Heck; Nathaniel I Martin; Simone Lemeer
Journal:  Mol Cell Proteomics       Date:  2018-09-19       Impact factor: 5.911

Review 7.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function.

Authors:  Dominique H Limoli; Christopher J Jones; Daniel J Wozniak
Journal:  Microbiol Spectr       Date:  2015-06

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  Effect of bacteriocin and exopolysaccharides isolated from probiotic on P. aeruginosa PAO1 biofilm.

Authors:  Vivek Sharma; Kusum Harjai; Geeta Shukla
Journal:  Folia Microbiol (Praha)       Date:  2017-09-14       Impact factor: 2.099

10.  Tryptophan inhibits biofilm formation by Pseudomonas aeruginosa.

Authors:  Kenneth S Brandenburg; Karien J Rodriguez; Jonathan F McAnulty; Christopher J Murphy; Nicholas L Abbott; Michael J Schurr; Charles J Czuprynski
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.